IDXX
IDEXX Laboratories, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -5.6% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 7 | 0 | 471.56K | $245.77M | n/a | n/a |
| Q2 2026 | 168 | 0 | 55.55M | $29.26B | +7 | −6 |
| Q1 2026 | 170 | +1 | 53.67M | $30.16B | +5 | −5 |
| Q4 2025 | 168 | +2 | 58.18M | $39.32B | +3 | n/a |
| Q3 2025 | 21 | +1 | 29.88M | $19.09B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.38M | $14.14B | +1 | −1 |
| Q1 2025 | 15 | -2 | 9.43M | $3.96B | n/a | −2 |
| Q4 2024 | 17 | -1 | 9.47M | $3.92B | n/a | −1 |
| Q3 2024 | 17 | +1 | 5.70M | $2.88B | +1 | n/a |
| Q2 2024 | 16 | n/a | 5.12M | $2.49B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 9.88M | n/a | $5.30B | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 8.37M | n/a | $4.49B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 3.55M | -2.6% | $1.91B | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 2.46M | +2.3% | $1.32B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | T. Rowe Price ✦ | 536.10K | -73.0% | $287.53M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (passief) | 413.83K | +18.9% | $221.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 269.88K | n/a | $144.75M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | AQR Capital Management ✦ | 223.32K | +27.0% | $118.69M | 0.1% | ▲ Add | 5 | SEC ↗ ×6 |
| 9 | Arrowstreet Capital ✦ | 206.14K | +8.0% | $110.56M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 188.17K | -14.3% | $100.92M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 11 | Millennium Management ✦ | 78.78K | +99.4% | $42.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 59.20K | Nieuw | $31.75M | 0.1% | New | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 43.38K | +3946.8% | $23.27M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 34.66K | +69.5% | $18.59M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 22.66K | -90.5% | $12.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 20.00K | -81.9% | $10.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 9.70K | -71.8% | $5.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 2.62K | -23.6% | $1.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $31.75M | 0.1% |
Verlaten
| Fisher Asset Management | $270,227 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,302 houders, 70.72M aandelen, $38.50B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 2.20K aand · $1.17M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie